

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 6.66282563 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.45961226 |
| 3 | * lymph vessel development (GO:0001945) | 6.02204304 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.96428819 |
| 5 | positive regulation of vasculogenesis (GO:2001214) | 5.77189090 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.76492416 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.76492416 |
| 8 | lymphangiogenesis (GO:0001946) | 5.60234572 |
| 9 | regulation of endothelial cell differentiation (GO:0045601) | 5.57476638 |
| 10 | surfactant homeostasis (GO:0043129) | 5.47232544 |
| 11 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.41826285 |
| 12 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 5.33997708 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.24923829 |
| 14 | regulation of vasculogenesis (GO:2001212) | 5.22411961 |
| 15 | blood vessel maturation (GO:0001955) | 5.14342423 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.87578442 |
| 17 | morphogenesis of an endothelium (GO:0003159) | 4.75931774 |
| 18 | endothelial tube morphogenesis (GO:0061154) | 4.75931774 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62082182 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55697224 |
| 21 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.48578145 |
| 22 | endothelial cell differentiation (GO:0045446) | 4.33073120 |
| 23 | chemical homeostasis within a tissue (GO:0048875) | 4.31490617 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.18326168 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.17776778 |
| 26 | transcytosis (GO:0045056) | 4.12762613 |
| 27 | negative T cell selection (GO:0043383) | 4.10638991 |
| 28 | negative thymic T cell selection (GO:0045060) | 4.07702314 |
| 29 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.01671780 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.88449286 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.85452695 |
| 32 | patterning of blood vessels (GO:0001569) | 3.78953996 |
| 33 | basement membrane organization (GO:0071711) | 3.71728700 |
| 34 | heart trabecula formation (GO:0060347) | 3.70568491 |
| 35 | tolerance induction (GO:0002507) | 3.69821596 |
| 36 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.68275878 |
| 37 | leukocyte aggregation (GO:0070486) | 3.65379489 |
| 38 | response to interleukin-15 (GO:0070672) | 3.65150127 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.63813022 |
| 40 | endothelial cell morphogenesis (GO:0001886) | 3.63067209 |
| 41 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.58922151 |
| 42 | endothelial cell chemotaxis (GO:0035767) | 3.56050490 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.54775900 |
| 44 | ovulation from ovarian follicle (GO:0001542) | 3.49816551 |
| 45 | thymic T cell selection (GO:0045061) | 3.49601266 |
| 46 | blood vessel endothelial cell migration (GO:0043534) | 3.44748700 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.42858493 |
| 48 | sprouting angiogenesis (GO:0002040) | 3.39639433 |
| 49 | negative regulation of stress fiber assembly (GO:0051497) | 3.39635905 |
| 50 | T cell migration (GO:0072678) | 3.39089584 |
| 51 | venous blood vessel morphogenesis (GO:0048845) | 3.37844582 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.36492128 |
| 53 | glomerular filtration (GO:0003094) | 3.36381108 |
| 54 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.35187397 |
| 55 | vasculogenesis (GO:0001570) | 3.34168440 |
| 56 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.33430641 |
| 57 | T cell selection (GO:0045058) | 3.32250775 |
| 58 | negative regulation of endothelial cell migration (GO:0010596) | 3.31852878 |
| 59 | positive T cell selection (GO:0043368) | 3.31615652 |
| 60 | renal filtration (GO:0097205) | 3.24649447 |
| 61 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.23785509 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.22661401 |
| 63 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.21308977 |
| 64 | blood vessel remodeling (GO:0001974) | 3.21122883 |
| 65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20244222 |
| 66 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.17954105 |
| 67 | angiogenesis involved in wound healing (GO:0060055) | 3.17569503 |
| 68 | lung vasculature development (GO:0060426) | 3.17454906 |
| 69 | positive regulation of tolerance induction (GO:0002645) | 3.16489666 |
| 70 | positive regulation of granulocyte differentiation (GO:0030854) | 3.15262744 |
| 71 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.13904978 |
| 72 | glomerular basement membrane development (GO:0032836) | 3.10315448 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08498250 |
| 74 | regulation of platelet aggregation (GO:0090330) | 3.08136843 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.07553479 |
| 76 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.06568584 |
| 77 | cellular extravasation (GO:0045123) | 3.04347852 |
| 78 | negative regulation of platelet activation (GO:0010544) | 3.03572158 |
| 79 | embryonic heart tube development (GO:0035050) | 3.02196539 |
| 80 | artery development (GO:0060840) | 2.99662393 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98933850 |
| 82 | detection of bacterium (GO:0016045) | 2.97890536 |
| 83 | adhesion of symbiont to host (GO:0044406) | 2.97690918 |
| 84 | coronary vasculature morphogenesis (GO:0060977) | 2.96277240 |
| 85 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95328546 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95328546 |
| 87 | cell adhesion mediated by integrin (GO:0033627) | 2.95217597 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95025906 |
| 89 | glomerular visceral epithelial cell development (GO:0072015) | 2.93147241 |
| 90 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.92888566 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92059773 |
| 92 | detection of other organism (GO:0098543) | 2.91712372 |
| 93 | sodium-independent organic anion transport (GO:0043252) | 2.91527386 |
| 94 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.91461808 |
| 95 | neutrophil activation involved in immune response (GO:0002283) | 2.91302159 |
| 96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90048771 |
| 97 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88839098 |
| 98 | modulation by symbiont of host defense response (GO:0052031) | 2.88839098 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88839098 |
| 100 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88839098 |
| 101 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88839098 |
| 102 | modulation by symbiont of host immune response (GO:0052553) | 2.88839098 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88185118 |
| 104 | endothelial cell proliferation (GO:0001935) | 2.85901705 |
| 105 | negative regulation of hemostasis (GO:1900047) | 2.84076061 |
| 106 | negative regulation of blood coagulation (GO:0030195) | 2.84076061 |
| 107 | negative regulation of innate immune response (GO:0045824) | 2.83342558 |
| 108 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.82885209 |
| 109 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82511862 |
| 110 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81220207 |
| 111 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81220207 |
| 112 | regulation of complement activation (GO:0030449) | 2.76434664 |
| 113 | negative regulation of vascular permeability (GO:0043116) | 2.74420519 |
| 114 | negative regulation of phagocytosis (GO:0050765) | 2.74021975 |
| 115 | endothelial cell migration (GO:0043542) | 2.73769018 |
| 116 | regulation of endothelial cell migration (GO:0010594) | 2.73712499 |
| 117 | cardiac myofibril assembly (GO:0055003) | 2.72439807 |
| 118 | positive regulation of cell junction assembly (GO:1901890) | 2.70143466 |
| 119 | positive regulation of focal adhesion assembly (GO:0051894) | 2.70143466 |
| 120 | cellular response to type I interferon (GO:0071357) | 2.69586038 |
| 121 | type I interferon signaling pathway (GO:0060337) | 2.69586038 |
| 122 | response to type I interferon (GO:0034340) | 2.69314606 |
| 123 | negative regulation of epithelial cell migration (GO:0010633) | 2.69210922 |
| 124 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.68128797 |
| 125 | regulation of protein activation cascade (GO:2000257) | 2.67891612 |
| 126 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.64564327 |
| 127 | negative regulation of coagulation (GO:0050819) | 2.63965771 |
| 128 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.62794281 |
| 129 | cell migration involved in heart development (GO:0060973) | 2.62431636 |
| 130 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60988248 |
| 131 | regulation of granulocyte differentiation (GO:0030852) | 2.60860741 |
| 132 | T cell receptor signaling pathway (GO:0050852) | 2.60468902 |
| 133 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.60086624 |
| 134 | glomerular epithelial cell development (GO:0072310) | 2.59503226 |
| 135 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.58103155 |
| 136 | cAMP biosynthetic process (GO:0006171) | 2.58066682 |
| 137 | regulation of endothelial cell proliferation (GO:0001936) | 2.55674513 |
| 138 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.55385242 |
| 139 | * regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.55052386 |
| 140 | substrate-dependent cell migration (GO:0006929) | 2.55012675 |
| 141 | regulation of B cell differentiation (GO:0045577) | 2.54971830 |
| 142 | trabecula formation (GO:0060343) | 2.54449606 |
| 143 | blood vessel morphogenesis (GO:0048514) | 2.54299434 |
| 144 | negative regulation of T cell apoptotic process (GO:0070233) | 2.54250939 |
| 145 | dendritic cell chemotaxis (GO:0002407) | 2.54159529 |
| 146 | response to muramyl dipeptide (GO:0032495) | 2.52932084 |
| 147 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.52333709 |
| 148 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.51829332 |
| 149 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.51806548 |
| 150 | positive regulation of endothelial cell migration (GO:0010595) | 2.50726997 |
| 151 | lymph node development (GO:0048535) | 2.49900498 |
| 152 | atrioventricular valve morphogenesis (GO:0003181) | 2.49771135 |
| 153 | gap junction assembly (GO:0016264) | 2.49524401 |
| 154 | positive regulation of B cell differentiation (GO:0045579) | 2.49177763 |
| 155 | phagocytosis, recognition (GO:0006910) | 2.49129620 |
| 156 | arginine catabolic process (GO:0006527) | 2.49000623 |
| 157 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.48992511 |
| 158 | establishment of endothelial barrier (GO:0061028) | 2.48991708 |
| 159 | neutrophil activation (GO:0042119) | 2.47835286 |
| 160 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.46000038 |
| 161 | glomerulus development (GO:0032835) | 2.45532870 |
| 162 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.44824160 |
| 163 | potassium ion import (GO:0010107) | 2.44589969 |
| 164 | lymphocyte migration (GO:0072676) | 2.44585030 |
| 165 | positive regulation of adherens junction organization (GO:1903393) | 2.44474679 |
| 166 | B cell receptor signaling pathway (GO:0050853) | 2.44379691 |
| 167 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.42878115 |
| 168 | fatty acid transmembrane transport (GO:1902001) | 2.42689140 |
| 169 | Notch signaling involved in heart development (GO:0061314) | 2.42521119 |
| 170 | negative regulation of angiogenesis (GO:0016525) | 2.42360073 |
| 171 | regulation of actin filament-based movement (GO:1903115) | 2.41653728 |
| 172 | mast cell activation (GO:0045576) | 2.41361727 |
| 173 | regulation of p38MAPK cascade (GO:1900744) | 2.40336856 |
| 174 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.39918953 |
| 175 | toxin metabolic process (GO:0009404) | 2.39209395 |
| 176 | negative regulation of type 2 immune response (GO:0002829) | 2.39151853 |
| 177 | activated T cell proliferation (GO:0050798) | 2.38744289 |
| 178 | regulation of vascular permeability (GO:0043114) | 2.38372486 |
| 179 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.37863564 |
| 180 | negative regulation of wound healing (GO:0061045) | 2.37181923 |
| 181 | artery morphogenesis (GO:0048844) | 2.37127856 |
| 182 | dendritic cell migration (GO:0036336) | 2.36837807 |
| 183 | fibril organization (GO:0097435) | 2.36599369 |
| 184 | ovulation (GO:0030728) | 2.35777561 |
| 185 | response to fluid shear stress (GO:0034405) | 2.35474546 |
| 186 | positive regulation of interleukin-4 production (GO:0032753) | 2.34830402 |
| 187 | positive regulation of macrophage differentiation (GO:0045651) | 2.32960477 |
| 188 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32565617 |
| 189 | lymphocyte chemotaxis (GO:0048247) | 2.32161937 |
| 190 | detection of external biotic stimulus (GO:0098581) | 2.31982693 |
| 191 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.30739812 |
| 192 | regulation of cell killing (GO:0031341) | 2.29995094 |
| 193 | regulation of extracellular matrix disassembly (GO:0010715) | 2.29793101 |
| 194 | signal complex assembly (GO:0007172) | 2.29105881 |
| 195 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.26531067 |
| 196 | positive regulation of cell killing (GO:0031343) | 2.25770885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25377126 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.92442369 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.78142610 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.35203672 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.27819633 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.98611500 |
| 7 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.93679365 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.64813668 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63274786 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.58827123 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52184927 |
| 12 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.44019232 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38418385 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32993081 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31611697 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.27731724 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22878455 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.12194406 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11807199 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.09685794 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09605578 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07655435 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02752869 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01340520 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94880597 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94347885 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93775879 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.92434574 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91104795 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91062345 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.86678761 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.83316807 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81822399 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81115507 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81107685 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80862445 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80842393 |
| 38 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79262508 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77541459 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74686191 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73975397 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73642081 |
| 43 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.73077832 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.73077832 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71885958 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71659742 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70976281 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70612783 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70086507 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69182809 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68257987 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68200086 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65848703 |
| 54 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.63308194 |
| 55 | * MAF_26560356_Chip-Seq_TH2_Human | 1.62940295 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62518795 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.62449845 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59990179 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59534056 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.58526986 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58127567 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58007960 |
| 63 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.57992314 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56413067 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56228178 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.55456281 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54770009 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53439484 |
| 69 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.51379624 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50868795 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.50858907 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47767144 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47624436 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47383140 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46991798 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45167055 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44750199 |
| 78 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.41815992 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41510922 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41296856 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38972831 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37195688 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37145844 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36842101 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33906415 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33537438 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33486550 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33225742 |
| 89 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31539167 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29794768 |
| 91 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.25007173 |
| 92 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.25007173 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23392147 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.22908827 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22041489 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22041489 |
| 97 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20177774 |
| 98 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.19513414 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19478137 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19474894 |
| 101 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19240590 |
| 102 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19120489 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18627714 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18459465 |
| 105 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.17792032 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17091573 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16818997 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16243868 |
| 109 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15899493 |
| 110 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15775141 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14491820 |
| 112 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14261722 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14239276 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13295349 |
| 115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12073782 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12025922 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11987144 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11335154 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08026472 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07250999 |
| 121 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07150649 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05967134 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05925855 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03695554 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03375933 |
| 126 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03319464 |
| 127 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03143773 |
| 128 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02265785 |
| 129 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00357683 |
| 130 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.00190169 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99125872 |
| 132 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98986732 |
| 133 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98986732 |
| 134 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98986732 |
| 135 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98356840 |
| 136 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97513560 |
| 137 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96640559 |
| 138 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96118819 |
| 139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95780669 |
| 140 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95139300 |
| 141 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94877223 |
| 142 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94668668 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94373104 |
| 144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92457483 |
| 145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91793877 |
| 146 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91045986 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90979656 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90932947 |
| 149 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90911416 |
| 150 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90524038 |
| 151 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88744444 |
| 152 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88509749 |
| 153 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88395635 |
| 154 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87699804 |
| 155 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87163985 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86922367 |
| 157 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85741118 |
| 158 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85355137 |
| 159 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.84021254 |
| 160 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83838376 |
| 161 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.83530510 |
| 162 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83418865 |
| 163 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83343025 |
| 164 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82794048 |
| 165 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82653411 |
| 166 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82585313 |
| 167 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82508680 |
| 168 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82002862 |
| 169 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81749068 |
| 170 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80740833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.99710051 |
| 2 | * MP0001879_abnormal_lymphatic_vessel | 4.80776290 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 4.78681456 |
| 4 | MP0004272_abnormal_basement_membrane | 3.80347523 |
| 5 | MP0003724_increased_susceptibility_to | 3.35277703 |
| 6 | MP0003436_decreased_susceptibility_to | 3.16745885 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.02373859 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.95159355 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.85263217 |
| 10 | MP0003828_pulmonary_edema | 2.78686846 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.77635700 |
| 12 | MP0006054_spinal_hemorrhage | 2.54123024 |
| 13 | MP0005671_abnormal_response_to | 2.44887157 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.43824037 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.31171677 |
| 16 | MP0006138_congestive_heart_failure | 2.30741888 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.26786161 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.22118891 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.17737497 |
| 20 | MP0003279_aneurysm | 2.13901479 |
| 21 | MP0000767_abnormal_smooth_muscle | 2.11369176 |
| 22 | MP0002933_joint_inflammation | 2.08174915 |
| 23 | MP0001800_abnormal_humoral_immune | 2.06243888 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.03801663 |
| 25 | MP0004036_abnormal_muscle_relaxation | 2.02828821 |
| 26 | MP0005360_urolithiasis | 2.02134958 |
| 27 | MP0005025_abnormal_response_to | 2.00789955 |
| 28 | MP0000685_abnormal_immune_system | 1.98327673 |
| 29 | MP0001958_emphysema | 1.96436940 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.94415086 |
| 31 | MP0001790_abnormal_immune_system | 1.93657766 |
| 32 | MP0005387_immune_system_phenotype | 1.93657766 |
| 33 | MP0002419_abnormal_innate_immunity | 1.93225420 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.92534458 |
| 35 | MP0002723_abnormal_immune_serum | 1.89801423 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.85913603 |
| 37 | MP0001819_abnormal_immune_cell | 1.83620371 |
| 38 | MP0005330_cardiomyopathy | 1.80595360 |
| 39 | MP0004147_increased_porphyrin_level | 1.80277698 |
| 40 | MP0002295_abnormal_pulmonary_circulatio | 1.79678649 |
| 41 | MP0009785_altered_susceptibility_to | 1.73486886 |
| 42 | MP0005165_increased_susceptibility_to | 1.72888953 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.71886533 |
| 44 | MP0004484_altered_response_of | 1.71693808 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.71278013 |
| 46 | MP0005595_abnormal_vascular_smooth | 1.71216241 |
| 47 | MP0005670_abnormal_white_adipose | 1.69375948 |
| 48 | MP0000249_abnormal_blood_vessel | 1.68561479 |
| 49 | MP0002972_abnormal_cardiac_muscle | 1.68194417 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.67021648 |
| 51 | MP0001544_abnormal_cardiovascular_syste | 1.63111776 |
| 52 | MP0005385_cardiovascular_system_phenoty | 1.63111776 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.62644559 |
| 54 | MP0004883_abnormal_blood_vessel | 1.62277129 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.59604642 |
| 56 | MP0002127_abnormal_cardiovascular_syste | 1.58226197 |
| 57 | MP0005164_abnormal_response_to | 1.57334708 |
| 58 | MP0002405_respiratory_system_inflammati | 1.56577257 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.56408685 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.55646902 |
| 61 | MP0002398_abnormal_bone_marrow | 1.52097339 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.51897140 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.51360654 |
| 64 | MP0006082_CNS_inflammation | 1.50669753 |
| 65 | MP0000343_altered_response_to | 1.50623442 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.48379879 |
| 67 | MP0000751_myopathy | 1.48108184 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.45354733 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.44796644 |
| 70 | MP0005503_abnormal_tendon_morphology | 1.43018290 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41971489 |
| 72 | MP0005620_abnormal_muscle_contractility | 1.41666284 |
| 73 | MP0010630_abnormal_cardiac_muscle | 1.40490346 |
| 74 | MP0004130_abnormal_muscle_cell | 1.40401494 |
| 75 | MP0000716_abnormal_immune_system | 1.40238409 |
| 76 | MP0002128_abnormal_blood_circulation | 1.39652782 |
| 77 | MP0003866_abnormal_defecation | 1.39506525 |
| 78 | MP0004947_skin_inflammation | 1.38942356 |
| 79 | MP0009379_abnormal_foot_pigmentation | 1.35103376 |
| 80 | MP0004085_abnormal_heartbeat | 1.32909676 |
| 81 | MP0003252_abnormal_bile_duct | 1.31477306 |
| 82 | MP0005390_skeleton_phenotype | 1.31469904 |
| 83 | MP0000230_abnormal_systemic_arterial | 1.31130062 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.30569270 |
| 85 | MP0005275_abnormal_skin_tensile | 1.30467694 |
| 86 | MP0000703_abnormal_thymus_morphology | 1.28291619 |
| 87 | MP0008004_abnormal_stomach_pH | 1.26982520 |
| 88 | MP0004381_abnormal_hair_follicle | 1.26247242 |
| 89 | MP0009697_abnormal_copulation | 1.25679364 |
| 90 | MP0000749_muscle_degeneration | 1.25062511 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.24852153 |
| 92 | MP0004510_myositis | 1.23283200 |
| 93 | MP0002009_preneoplasia | 1.22560053 |
| 94 | MP0002722_abnormal_immune_system | 1.20988042 |
| 95 | MP0001845_abnormal_inflammatory_respons | 1.18839722 |
| 96 | MP0005365_abnormal_bile_salt | 1.17398490 |
| 97 | MP0000689_abnormal_spleen_morphology | 1.16836110 |
| 98 | MP0003950_abnormal_plasma_membrane | 1.16273022 |
| 99 | MP0001614_abnormal_blood_vessel | 1.15419253 |
| 100 | MP0008260_abnormal_autophagy | 1.13338080 |
| 101 | MP0003566_abnormal_cell_adhesion | 1.12796087 |
| 102 | MP0002429_abnormal_blood_cell | 1.12266696 |
| 103 | MP0002925_abnormal_cardiovascular_devel | 1.12106468 |
| 104 | MP0000858_altered_metastatic_potential | 1.12024505 |
| 105 | MP0002132_abnormal_respiratory_system | 1.11557517 |
| 106 | MP0010329_abnormal_lipoprotein_level | 1.09364484 |
| 107 | MP0004087_abnormal_muscle_fiber | 1.04666941 |
| 108 | MP0009384_cardiac_valve_regurgitation | 1.00527574 |
| 109 | MP0009840_abnormal_foam_cell | 0.98814432 |
| 110 | MP0005083_abnormal_biliary_tract | 0.97392969 |
| 111 | MP0001542_abnormal_bone_strength | 0.91257487 |
| 112 | MP0002108_abnormal_muscle_morphology | 0.90799378 |
| 113 | MP0003448_altered_tumor_morphology | 0.90599922 |
| 114 | MP0002133_abnormal_respiratory_system | 0.90426468 |
| 115 | MP0005388_respiratory_system_phenotype | 0.90426468 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.90002147 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.89359515 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.89188453 |
| 119 | MP0005332_abnormal_amino_acid | 0.88315939 |
| 120 | MP0008469_abnormal_protein_level | 0.88269990 |
| 121 | MP0001545_abnormal_hematopoietic_system | 0.87779561 |
| 122 | MP0005397_hematopoietic_system_phenotyp | 0.87779561 |
| 123 | MP0003303_peritoneal_inflammation | 0.87559163 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.87467816 |
| 125 | MP0000266_abnormal_heart_morphology | 0.87429947 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.85901974 |
| 127 | MP0001873_stomach_inflammation | 0.83972661 |
| 128 | MP0005409_darkened_coat_color | 0.81728387 |
| 129 | MP0002396_abnormal_hematopoietic_system | 0.80644177 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.80545076 |
| 131 | MP0003091_abnormal_cell_migration | 0.79376688 |
| 132 | MP0009278_abnormal_bone_marrow | 0.78857054 |
| 133 | MP0001851_eye_inflammation | 0.77406065 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.77370298 |
| 135 | MP0009763_increased_sensitivity_to | 0.77334035 |
| 136 | MP0009764_decreased_sensitivity_to | 0.75460692 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.74410772 |
| 138 | MP0001756_abnormal_urination | 0.72599146 |
| 139 | MP0003690_abnormal_glial_cell | 0.72072646 |
| 140 | MP0005171_absent_coat_pigmentation | 0.71147546 |
| 141 | MP0001915_intracranial_hemorrhage | 0.70420956 |
| 142 | MP0002254_reproductive_system_inflammat | 0.69458075 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.69100031 |
| 144 | MP0003075_altered_response_to | 0.66766181 |
| 145 | MP0001784_abnormal_fluid_regulation | 0.65661210 |
| 146 | MP0004019_abnormal_vitamin_homeostasis | 0.65070124 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.64587408 |
| 148 | MP0003943_abnormal_hepatobiliary_system | 0.63805743 |
| 149 | MP0002118_abnormal_lipid_homeostasis | 0.62538151 |
| 150 | MP0003638_abnormal_response/metabolism_ | 0.62455730 |
| 151 | MP0004185_abnormal_adipocyte_glucose | 0.62409142 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.62035452 |
| 153 | MP0002136_abnormal_kidney_physiology | 0.61875358 |
| 154 | MP0003045_fibrosis | 0.60605819 |
| 155 | MP0005023_abnormal_wound_healing | 0.60578193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polycythemia (HP:0001901) | 6.11668589 |
| 2 | Hematochezia (HP:0002573) | 5.57579235 |
| 3 | Spontaneous hematomas (HP:0007420) | 5.29331428 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.79185052 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.68026561 |
| 6 | Esophageal varix (HP:0002040) | 4.50522263 |
| 7 | Stomatitis (HP:0010280) | 4.33589926 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.24739937 |
| 9 | Broad metatarsal (HP:0001783) | 4.22752815 |
| 10 | Myositis (HP:0100614) | 4.07958269 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.04114911 |
| 12 | Cerebral hemorrhage (HP:0001342) | 3.77420753 |
| 13 | Ventricular tachycardia (HP:0004756) | 3.66282088 |
| 14 | Visceral angiomatosis (HP:0100761) | 3.51206525 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.48740219 |
| 16 | Epistaxis (HP:0000421) | 3.46363601 |
| 17 | Nonimmune hydrops fetalis (HP:0001790) | 3.43082587 |
| 18 | Purpura (HP:0000979) | 3.41329734 |
| 19 | Muscle fiber splitting (HP:0003555) | 3.40619388 |
| 20 | Hemangiomatosis (HP:0007461) | 3.40526266 |
| 21 | Orchitis (HP:0100796) | 3.39876689 |
| 22 | Sudden death (HP:0001699) | 3.38997594 |
| 23 | Lymphangioma (HP:0100764) | 3.38455499 |
| 24 | Conjunctival telangiectasia (HP:0000524) | 3.26436978 |
| 25 | Abnormal platelet volume (HP:0011876) | 3.21094968 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.09857101 |
| 27 | Menorrhagia (HP:0000132) | 3.09697252 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.07869554 |
| 29 | Optic neuritis (HP:0100653) | 3.07423432 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.07423432 |
| 31 | Increased connective tissue (HP:0009025) | 3.04845204 |
| 32 | T lymphocytopenia (HP:0005403) | 3.03572879 |
| 33 | Cerebral aneurysm (HP:0004944) | 3.02235017 |
| 34 | Atrial fibrillation (HP:0005110) | 3.02105318 |
| 35 | Petechiae (HP:0000967) | 2.98995317 |
| 36 | Short hallux (HP:0010109) | 2.97130221 |
| 37 | Hypoglycemic coma (HP:0001325) | 2.97008630 |
| 38 | Increased IgE level (HP:0003212) | 2.95732348 |
| 39 | Aortic aneurysm (HP:0004942) | 2.94558215 |
| 40 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.86400405 |
| 41 | Complement deficiency (HP:0004431) | 2.84637378 |
| 42 | Cavernous hemangioma (HP:0001048) | 2.80095649 |
| 43 | Increased mean platelet volume (HP:0011877) | 2.78745338 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.77059495 |
| 45 | Portal hypertension (HP:0001409) | 2.76531692 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.75719411 |
| 47 | Primary atrial arrhythmia (HP:0001692) | 2.75527415 |
| 48 | Supraventricular arrhythmia (HP:0005115) | 2.74940149 |
| 49 | Mesangial abnormality (HP:0001966) | 2.74101943 |
| 50 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.72845661 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.68957979 |
| 52 | Pulmonary artery stenosis (HP:0004415) | 2.65059752 |
| 53 | Lipoatrophy (HP:0100578) | 2.64797812 |
| 54 | Gingival bleeding (HP:0000225) | 2.64547102 |
| 55 | Pustule (HP:0200039) | 2.62768909 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.62514898 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.62286882 |
| 58 | Supraventricular tachycardia (HP:0004755) | 2.60020395 |
| 59 | Dilatation of the ascending aorta (HP:0005111) | 2.58964189 |
| 60 | Congenital, generalized hypertrichosis (HP:0004540) | 2.57701115 |
| 61 | Peritonitis (HP:0002586) | 2.56256971 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.55869332 |
| 63 | Hyperactive renin-angiotensin system (HP:0000841) | 2.55535100 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.51760703 |
| 65 | Aortic dissection (HP:0002647) | 2.48506241 |
| 66 | Vascular tortuosity (HP:0004948) | 2.48410585 |
| 67 | Absent hand (HP:0004050) | 2.47485011 |
| 68 | Obstructive lung disease (HP:0006536) | 2.44830665 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44830665 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43723418 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.43047291 |
| 72 | Abnormality of the hepatic vasculature (HP:0006707) | 2.42141343 |
| 73 | Mucosal telangiectasiae (HP:0100579) | 2.41494743 |
| 74 | Vasculitis (HP:0002633) | 2.40856065 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40833431 |
| 76 | Hypokalemic alkalosis (HP:0001949) | 2.39638295 |
| 77 | Meningitis (HP:0001287) | 2.38973204 |
| 78 | Venous insufficiency (HP:0005293) | 2.35955826 |
| 79 | Keratoconjunctivitis sicca (HP:0001097) | 2.35438479 |
| 80 | Cellulitis (HP:0100658) | 2.33696770 |
| 81 | Arterial tortuosity (HP:0005116) | 2.33559992 |
| 82 | Adactyly (HP:0009776) | 2.32343529 |
| 83 | Aneurysm (HP:0002617) | 2.31757282 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.30427342 |
| 85 | Encephalitis (HP:0002383) | 2.29007314 |
| 86 | Episodic fever (HP:0001954) | 2.28137631 |
| 87 | Chest pain (HP:0100749) | 2.27152328 |
| 88 | Asymmetric septal hypertrophy (HP:0001670) | 2.27114855 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.26284892 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 2.26170554 |
| 91 | Hemoptysis (HP:0002105) | 2.25989754 |
| 92 | Abnormality of T cells (HP:0002843) | 2.25987238 |
| 93 | Nephritis (HP:0000123) | 2.25211497 |
| 94 | Protrusio acetabuli (HP:0003179) | 2.25059515 |
| 95 | Leukocytosis (HP:0001974) | 2.24518622 |
| 96 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22580153 |
| 97 | Chondrocalcinosis (HP:0000934) | 2.21813043 |
| 98 | Gastrointestinal inflammation (HP:0004386) | 2.21806568 |
| 99 | Emphysema (HP:0002097) | 2.21217847 |
| 100 | Pulmonary hypertension (HP:0002092) | 2.20951762 |
| 101 | Spondylolisthesis (HP:0003302) | 2.20520430 |
| 102 | Venous abnormality (HP:0002624) | 2.20469182 |
| 103 | Granulocytopenia (HP:0001913) | 2.18791622 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.18591579 |
| 105 | Mediastinal lymphadenopathy (HP:0100721) | 2.18363544 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.18003396 |
| 107 | Calf muscle hypertrophy (HP:0008981) | 2.17564039 |
| 108 | Growth hormone excess (HP:0000845) | 2.17334915 |
| 109 | Difficulty running (HP:0009046) | 2.16771017 |
| 110 | EMG: myopathic abnormalities (HP:0003458) | 2.16456994 |
| 111 | Inflammation of the large intestine (HP:0002037) | 2.16454609 |
| 112 | Intrahepatic cholestasis (HP:0001406) | 2.16378936 |
| 113 | Hyperlipoproteinemia (HP:0010980) | 2.15784656 |
| 114 | Dilated cardiomyopathy (HP:0001644) | 2.15120489 |
| 115 | Abnormality of Sharpey fibers (HP:0100685) | 2.13129689 |
| 116 | Ketoacidosis (HP:0001993) | 2.11652146 |
| 117 | Stroke (HP:0001297) | 2.11151060 |
| 118 | Gingivitis (HP:0000230) | 2.10442796 |
| 119 | Joint swelling (HP:0001386) | 2.09819221 |
| 120 | Xanthomatosis (HP:0000991) | 2.09561703 |
| 121 | Amyloidosis (HP:0011034) | 2.08163398 |
| 122 | Microcytic anemia (HP:0001935) | 2.06456226 |
| 123 | Exercise-induced myalgia (HP:0003738) | 2.05337325 |
| 124 | Increased IgM level (HP:0003496) | 2.04604829 |
| 125 | Spinal rigidity (HP:0003306) | 2.03397072 |
| 126 | Joint hemorrhage (HP:0005261) | 2.02502835 |
| 127 | Recurrent bronchitis (HP:0002837) | 2.02129479 |
| 128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.01570573 |
| 129 | Absent toe (HP:0010760) | 2.01347997 |
| 130 | Premature rupture of membranes (HP:0001788) | 2.01235635 |
| 131 | Facial diplegia (HP:0001349) | 2.01029841 |
| 132 | Slender build (HP:0001533) | 2.00185423 |
| 133 | Myoglobinuria (HP:0002913) | 2.00076449 |
| 134 | Eosinophilia (HP:0001880) | 1.99934547 |
| 135 | Arterial thrombosis (HP:0004420) | 1.99761354 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.99290497 |
| 137 | Joint stiffness (HP:0001387) | 1.98924503 |
| 138 | Mitral stenosis (HP:0001718) | 1.97517228 |
| 139 | Bone cyst (HP:0012062) | 1.96703752 |
| 140 | Vertebral compression fractures (HP:0002953) | 1.96628401 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.95914685 |
| 142 | Prolonged partial thromboplastin time (HP:0003645) | 1.95793352 |
| 143 | Abnormality of the calf musculature (HP:0001430) | 1.94948975 |
| 144 | Impaired platelet aggregation (HP:0003540) | 1.94917824 |
| 145 | Abnormal platelet function (HP:0011869) | 1.94917824 |
| 146 | Hypoplasia of the iris (HP:0007676) | 1.94884972 |
| 147 | Acanthosis nigricans (HP:0000956) | 1.93874914 |
| 148 | Lymphopenia (HP:0001888) | 1.93459963 |
| 149 | Systemic lupus erythematosus (HP:0002725) | 1.93373404 |
| 150 | Abnormality of complement system (HP:0005339) | 1.93242751 |
| 151 | Hypergammaglobulinemia (HP:0010702) | 1.93134112 |
| 152 | Round ear (HP:0100830) | 1.92764432 |
| 153 | Distal lower limb muscle weakness (HP:0009053) | 1.92336095 |
| 154 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90601762 |
| 155 | Bruising susceptibility (HP:0000978) | 1.90342709 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.90133669 |
| 157 | Pulmonary embolism (HP:0002204) | 1.89998999 |
| 158 | Glomerulonephritis (HP:0000099) | 1.89935726 |
| 159 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89165889 |
| 160 | Autoimmune hemolytic anemia (HP:0001890) | 1.87316907 |
| 161 | Hypoplastic ischia (HP:0003175) | 1.86593368 |
| 162 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84710495 |
| 163 | Papilloma (HP:0012740) | 1.84397477 |
| 164 | Verrucae (HP:0200043) | 1.84397477 |
| 165 | Colitis (HP:0002583) | 1.82660350 |
| 166 | Hypertriglyceridemia (HP:0002155) | 1.82016777 |
| 167 | Cardiomegaly (HP:0001640) | 1.81973930 |
| 168 | Abnormality of the sella turcica (HP:0002679) | 1.80321439 |
| 169 | Potter facies (HP:0002009) | 1.80291478 |
| 170 | Facial shape deformation (HP:0011334) | 1.80291478 |
| 171 | Ketosis (HP:0001946) | 1.80246310 |
| 172 | Striae distensae (HP:0001065) | 1.80233605 |
| 173 | Dysostosis multiplex (HP:0000943) | 1.79248019 |
| 174 | Abnormality of eosinophils (HP:0001879) | 1.78022012 |
| 175 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77946250 |
| 176 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77946250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.11211967 |
| 2 | KDR | 5.97944492 |
| 3 | TGFBR2 | 4.93328013 |
| 4 | MAP4K1 | 4.00230349 |
| 5 | MYLK | 2.77158132 |
| 6 | PDK2 | 2.54723494 |
| 7 | TGFBR1 | 2.49358851 |
| 8 | GRK6 | 2.42638312 |
| 9 | RIPK4 | 2.38892911 |
| 10 | ZAP70 | 2.31893257 |
| 11 | TXK | 2.13478579 |
| 12 | PTK2B | 2.05831802 |
| 13 | PRPF4B | 1.98091261 |
| 14 | GRK1 | 1.97400988 |
| 15 | BTK | 1.88850303 |
| 16 | EPHB2 | 1.88214980 |
| 17 | ERN1 | 1.83435272 |
| 18 | TAOK3 | 1.80511630 |
| 19 | TNK2 | 1.71378256 |
| 20 | TTN | 1.67461477 |
| 21 | JAK3 | 1.67287321 |
| 22 | HCK | 1.53484264 |
| 23 | MAPK15 | 1.49150403 |
| 24 | RIPK1 | 1.46699346 |
| 25 | DMPK | 1.45078727 |
| 26 | PDGFRA | 1.41753271 |
| 27 | SYK | 1.41346586 |
| 28 | PIK3CG | 1.41167744 |
| 29 | AKT3 | 1.38367487 |
| 30 | MAP3K13 | 1.35899433 |
| 31 | WNK4 | 1.35086482 |
| 32 | TESK2 | 1.30318653 |
| 33 | MAPK12 | 1.28702893 |
| 34 | LCK | 1.27040602 |
| 35 | FGFR4 | 1.26938048 |
| 36 | INSRR | 1.23995945 |
| 37 | BLK | 1.23964012 |
| 38 | FER | 1.23013266 |
| 39 | PTK6 | 1.22738494 |
| 40 | MAP2K3 | 1.12890721 |
| 41 | BCKDK | 1.11224653 |
| 42 | PHKG1 | 1.10871567 |
| 43 | PHKG2 | 1.10871567 |
| 44 | TRIB3 | 1.10598017 |
| 45 | IRAK4 | 1.10512568 |
| 46 | SIK3 | 1.07853324 |
| 47 | LYN | 1.03250430 |
| 48 | MAP3K3 | 1.00068851 |
| 49 | PRKG2 | 0.98910823 |
| 50 | MAPK7 | 0.98729981 |
| 51 | PRKD1 | 0.98370960 |
| 52 | LMTK2 | 0.97428326 |
| 53 | MAP3K14 | 0.97207896 |
| 54 | NUAK1 | 0.94721145 |
| 55 | MARK2 | 0.93812688 |
| 56 | BMX | 0.93704689 |
| 57 | EPHB1 | 0.91625944 |
| 58 | NEK9 | 0.90701323 |
| 59 | FGFR2 | 0.89292479 |
| 60 | IKBKB | 0.88605233 |
| 61 | CAMKK2 | 0.86479691 |
| 62 | HIPK2 | 0.84964207 |
| 63 | PRKAA2 | 0.84923984 |
| 64 | CSF1R | 0.83625317 |
| 65 | CSK | 0.83496597 |
| 66 | CAMKK1 | 0.80359037 |
| 67 | CAMK1D | 0.80244289 |
| 68 | CDC42BPA | 0.79523933 |
| 69 | STK38 | 0.79494656 |
| 70 | STK39 | 0.78614782 |
| 71 | GRK7 | 0.77404025 |
| 72 | PAK4 | 0.76250079 |
| 73 | CAMK1G | 0.72242122 |
| 74 | PDK1 | 0.71765621 |
| 75 | DYRK1B | 0.71001493 |
| 76 | OXSR1 | 0.69581791 |
| 77 | PAK2 | 0.69148845 |
| 78 | PKN2 | 0.68519066 |
| 79 | RPS6KC1 | 0.68244690 |
| 80 | RPS6KL1 | 0.68244690 |
| 81 | PAK3 | 0.67785705 |
| 82 | EPHA3 | 0.66887209 |
| 83 | MAP2K2 | 0.66464760 |
| 84 | TESK1 | 0.65510991 |
| 85 | PDK4 | 0.65295552 |
| 86 | PDK3 | 0.65295552 |
| 87 | LRRK2 | 0.63043187 |
| 88 | TAOK2 | 0.62970454 |
| 89 | TAOK1 | 0.62144132 |
| 90 | DDR2 | 0.60105710 |
| 91 | FGFR3 | 0.59305982 |
| 92 | KSR2 | 0.59239240 |
| 93 | GSK3A | 0.58784455 |
| 94 | RPS6KA6 | 0.58732583 |
| 95 | FYN | 0.58020756 |
| 96 | FGR | 0.58008677 |
| 97 | PRKCH | 0.57968206 |
| 98 | IRAK1 | 0.57752305 |
| 99 | MAPK11 | 0.55737135 |
| 100 | TBK1 | 0.55348186 |
| 101 | PRKCQ | 0.55316521 |
| 102 | TYK2 | 0.55304782 |
| 103 | ROCK1 | 0.54108116 |
| 104 | ILK | 0.53083989 |
| 105 | NLK | 0.52134604 |
| 106 | OBSCN | 0.51969171 |
| 107 | RPS6KA2 | 0.51476946 |
| 108 | PRKD2 | 0.49409520 |
| 109 | TRPM7 | 0.49254005 |
| 110 | MAP2K1 | 0.48588869 |
| 111 | SIK1 | 0.48426395 |
| 112 | PDGFRB | 0.48308649 |
| 113 | IGF1R | 0.47007668 |
| 114 | SIK2 | 0.45753952 |
| 115 | JAK1 | 0.44804116 |
| 116 | FRK | 0.44213917 |
| 117 | CAMK4 | 0.44148875 |
| 118 | ADRBK1 | 0.44140586 |
| 119 | MAPKAPK3 | 0.43898671 |
| 120 | PIK3CA | 0.43766282 |
| 121 | MAP3K6 | 0.42735413 |
| 122 | STK10 | 0.41945338 |
| 123 | KIT | 0.41916268 |
| 124 | PRKCE | 0.39918003 |
| 125 | SMG1 | 0.39484030 |
| 126 | JAK2 | 0.38313819 |
| 127 | PTK2 | 0.37356775 |
| 128 | BCR | 0.37206227 |
| 129 | GRK5 | 0.36440020 |
| 130 | MET | 0.34750155 |
| 131 | EGFR | 0.34590370 |
| 132 | PIM1 | 0.34435751 |
| 133 | INSR | 0.34313372 |
| 134 | PDPK1 | 0.34298720 |
| 135 | SGK3 | 0.33538284 |
| 136 | MAP3K7 | 0.32765687 |
| 137 | DAPK3 | 0.31095779 |
| 138 | SRC | 0.30415199 |
| 139 | FES | 0.29804926 |
| 140 | PRKAA1 | 0.27815929 |
| 141 | DAPK2 | 0.27251895 |
| 142 | TEC | 0.26301658 |
| 143 | MAP3K11 | 0.25272902 |
| 144 | MAPK4 | 0.25169760 |
| 145 | PKN1 | 0.25147107 |
| 146 | PRKACB | 0.25014051 |
| 147 | RET | 0.24935249 |
| 148 | ITK | 0.24669746 |
| 149 | MARK3 | 0.23522855 |
| 150 | PRKACG | 0.20717747 |
| 151 | IKBKE | 0.20307022 |
| 152 | NEK6 | 0.19528019 |
| 153 | MAP3K1 | 0.18662396 |
| 154 | CAMK1 | 0.16225978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.00071426 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60273736 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47061475 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25392764 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15685130 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15070955 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.11554673 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.06396942 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.03452892 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03331581 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01173461 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97399845 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95684716 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.94726838 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93674209 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93330324 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.87349627 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.87164037 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.85847503 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.83763052 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.81435141 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81081974 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79973512 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71548159 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70923518 |
| 26 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.69627597 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69146203 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61905397 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56149541 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55449846 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54285950 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.53607114 |
| 33 | Adherens junction_Homo sapiens_hsa04520 | 1.50735712 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.50438169 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48925952 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44780540 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43579052 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42882581 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40341338 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38191929 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35678323 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33702135 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33076107 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32168552 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30556367 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28829727 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26046227 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25041683 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24906745 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.23970834 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16222344 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16153164 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15792295 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13727675 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13390074 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.10758384 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10674192 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05928258 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.04807940 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04349251 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04042379 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 1.03148630 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02380082 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01523199 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 1.00009259 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99859884 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99161152 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.98935565 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98143452 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95315556 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94859027 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.94447113 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94398496 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93929211 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.92476114 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90825905 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90366690 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89936051 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89769018 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.89444488 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.88287674 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86411835 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86226092 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.86138254 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85729876 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85671581 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85666921 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.83917053 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.82906121 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.81776953 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.81626945 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79573414 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79013160 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78907910 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78708515 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77519512 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76948789 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76309767 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76072486 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75964908 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75461249 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73556821 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72821508 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71564396 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71255753 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.70972573 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.70679422 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.70029533 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.69896336 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67826248 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67584206 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66340375 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66010926 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64843213 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64797534 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64314376 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64183637 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63866030 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63616267 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62516250 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62433697 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61406010 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61392042 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58420299 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57248677 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57235595 |
| 127 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57212892 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55963915 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54864736 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54394289 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54319717 |
| 132 | Axon guidance_Homo sapiens_hsa04360 | 0.54173851 |
| 133 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53462197 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53408648 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52358397 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51462206 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51150228 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50984048 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.49349236 |
| 140 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49059868 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48601918 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47959406 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47908916 |
| 144 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47361169 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47273182 |
| 146 | Salmonella infection_Homo sapiens_hsa05132 | 0.47108247 |
| 147 | Lysine degradation_Homo sapiens_hsa00310 | 0.46930266 |
| 148 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46811241 |
| 149 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46601007 |
| 150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46370703 |
| 151 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46259342 |
| 152 | Legionellosis_Homo sapiens_hsa05134 | 0.46200267 |
| 153 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45554951 |
| 154 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42996718 |
| 155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42651835 |
| 156 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41036034 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40188636 |
| 158 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39346051 |
| 159 | Mineral absorption_Homo sapiens_hsa04978 | 0.37920719 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.37505541 |
| 161 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36347095 |
| 162 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36312533 |
| 163 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35879804 |

